CoChat

Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation

Li, Baoman, Zhang, Shiquen, Li, Min, Hertz, Leif, Peng, Liang · 2009 · Psychopharmacology

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

Introduction We have recently shown that fluoxetine, a serotonin-specific reuptake inhibitor (SSRI), has low micromolar affinity for the 5-HT(2C) receptor (but not for 5-HT(2A) and 5-HT(2B) receptors) in primary cultures of mouse astrocytes. This was determined as phosphorylation (stimulation) of extracellular-regulated kinase 1 and 2 (ERK(1/2)) by transactivation-mediated phosphorylation of the epidermal growth factor (EGF) receptor, followed by conventional EGF receptor signaling (Li et al., Psychopharmacology 194:333-334, 2007). Paroxetine has an identical effect. The present study shows that chronic fluoxetine treatment with even higher affinity (EC(50) = 0.5-2.0 microM) upregulates Ca(2+)-dependent phospholipase A(2) (cPLA(2)), which releases arachidonic acid from the sn-2 position of membrane-bound phospholipid, without effect on secretory PLA(2) (sPLA(2)) and intracellular PLA(2) (iPLA(2)). Discussion This demonstration replicates the fluoxetine-induced cPLA(2) upregulation in rat brain shown by Rao et al. (Pharmacogenomics J 6:413-420, 2006) and provides the new information that upregulation (1) occurs in astrocytes, (2) is evoked by stimulation of 5-HT(2B) receptor, and (3) requires transactivation-mediated ERK(1/2) phosphorylation. Similar upregulation of cPLA(2) in intact brain in response to 5-HT(2)-mediated signaling by elevated serotonin levels and/or an SSRI during antidepressant treatment may explain the repeatedly reported ability of SSRIs to normalize region…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-009-1631-3

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 81 references

Cited by

See all 53

Metadata

Authors
Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L.
Affiliations
China Medical University (CN)
Corresponding author
Peng, Liang
Venue
Psychopharmacology
Published
2009-08-07
Volume
207
Issue
1
Pages
1-12
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2068783760
Cited by
52
References
81
Citations by year
2026: 2 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 7 · 2014: 2 · 2013: 6 · 2012: 7
FWCI
2.49
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
fluoxetine, 5-HT2B receptor, astrocytes, cytosolic phospholipase A2, ERK1/2 phosphorylation, transcriptional activation, EGF receptor signaling, arachidonic acid, serotonin, selective serotonin reuptake inhibitors, major depressive disorder, brain glucose metabolism, chronic drug administration, antidepressant mechanism, neuroinflammation
MeSH terms
Animals, Astrocytes, Cells, Cultured, Cerebral Cortex, Dose-Response Relationship, Drug, Enzyme Inhibitors, Fluoxetine, Gene Expression Regulation, Indoles, Phosphorylation, RNA, Messenger, Time Factors, Urea, Selective Serotonin Reuptake Inhibitors, Mitogen-Activated Protein Kinase 1, Receptor, Serotonin, 5-HT2B, Mitogen-Activated Protein Kinase 3, Mice, Phospholipases A2, Serotonin 5-HT2 Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. https://app.cochat.ai/papers/10.1007/s00213-009-1631-3
The paper
Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L. (2009). Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology. https://doi.org/10.1007/s00213-009-1631-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.